Replies to post #248122 on Biotech Values

[DewDiligence]

TSBX -43%/AH on purportedly-positive phase-1 data in CRC:

https://www.globenewswire.com/news-release/2024/08/14/2930436/0/en/Turnstone-Biologics-Corp-Reports-Positive-Initial-Data-from-Phase-1-Trial-of-TIDAL-01-in-Metastatic-Colorectal-Cancer.html

The stock is down almost 90% from its IPO one year ago (#msg-172401448).